14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Nabriva Therapeutics AG Stock and on which exchange is it traded?
The symbol for Nabriva Therapeutics AG is NBRV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Nabriva Therapeutics AG Stock?
Nabriva Therapeutics AG holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Nabriva Therapeutics AG Stock?
Nabriva Therapeutics AG Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Nabriva Therapeutics AG Stock.

What's the current price of Nabriva Therapeutics AG Stock?
As of the end of day on the Nov 24, 2023, the price of an Nabriva Therapeutics AG (NBRV) share was $1.42.

What is the 52-week high and low for Nabriva Therapeutics AG Stock?
The 52-week high for Nabriva Therapeutics AG Stock is $2.87 and the 52-week low is $0.621.

What is the market capitalization of Nabriva Therapeutics AG Stock?
As of the Nov 24, 2023, the market capitalization of Nabriva Therapeutics AG is 4.546M.
Click to get the best stock tips daily for free!

About Nabriva Therapeutics AG

Nabriva Therapeutics AG Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also dev... NBRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT